Transarterial Chemoembolization Combined with Atezolizumab Plus Bevacizumab or Lenvatinib for Unresectable Hepatocellular Carcinoma: A Propensity Score Matched Study

Chenghao Zhao,* Zhanwang Xiang,* Mingan Li, Haofan Wang, Huan Liu, Huzheng Yan, Mingsheng Huang Department of Interventional Radiology, the Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, 510630, People’s Republic of China*These authors contributed equally to this workCor...

Descrizione completa

Dettagli Bibliografici

Autori principali:	Zhao C, Xiang Z, Li M, Wang H, Liu H, Yan H, Huang M
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	Dove Medical Press 2023-07-01
Serie:	Journal of Hepatocellular Carcinoma
Soggetti:	atezolizumab plus bevacizumab lenvatinib transarterial chemoembolization hepatocellular carcinoma efficacy
Accesso online:	https://www.dovepress.com/transarterial-chemoembolization-combined-with-atezolizumab-plus-bevaci-peer-reviewed-fulltext-article-JHC
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!